{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:14:04Z","timestamp":1760645644655},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T00:00:00Z","timestamp":1239062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00259-009-1126-9","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T04:09:37Z","timestamp":1238990977000},"page":"1176-1184","source":"Crossref","is-referenced-by-count":36,"title":["Positron emission tomography in patients suffering from HIV-1 infection"],"prefix":"10.1007","volume":"36","author":[{"given":"Mike","family":"Sathekge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"van de Wiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,7]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1741-7015-6-31","volume":"6","author":"M Wainberg","year":"2008","unstructured":"Wainberg M, Jeang K. 25 years of HIV-1 research \u2013 progress and perspectives. BMC Med 2008;6:31.","journal-title":"BMC Med"},{"key":"1126_CR2","unstructured":"UNAIDS. Epidemiology slides. Joint United Nations Programme on HIV\/AIDS. http:\/\/www.unaids.org\/en\/knowledgecentre\/hivdata\/epidemiology\/epislides.asp . Accessed 26 Mar 2009."},{"key":"1126_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11904-006-0002-5","volume":"3","author":"H Kelleher","year":"2006","unstructured":"Kelleher H, Zaunders J. Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection. Curr HIV\/AIDS Rep 2006;3:5\u201312. doi: 10.1007\/s11904-006-0002-5 .","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1126_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02976619","volume":"25","author":"R Samuel","year":"2002","unstructured":"Samuel R, Bettiker R, Suh B. AIDS related opportunistic infections, going but not gone. Arch Pharm Res 2002;25:215\u201328.","journal-title":"Arch Pharm Res"},{"key":"1126_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-230X(08)00409-0","volume":"101","author":"M Cadogan","year":"2008","unstructured":"Cadogan M, Dalgleish A. HIV induced AIDS and related cancers: chronic immune activation and future therapeutic strategies. Adv Cancer Res 2008;101:349\u201395. doi: 10.1016\/S0065-230X(08)00409-0 .","journal-title":"Adv Cancer Res"},{"key":"1126_CR6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1570162043351002","volume":"2","author":"Y Aoki","year":"2004","unstructured":"Aoki Y, Tosato G. Neoplastic conditions in the context of HIV-1 infection. Curr HIV Res 2004;2:343\u20139.","journal-title":"Curr HIV Res"},{"key":"1126_CR7","first-page":"223","volume":"104","author":"C Porter","year":"2008","unstructured":"Porter C, Laditka J, Cornman C, Davis D, Logan W. Prevalence of AIDS dementia complex: results from a state-wide population-based registry of Alzheimer's disease and related disorders. J S C Med Assoc 2008;104:223\u201336.","journal-title":"J S C Med Assoc"},{"key":"1126_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0001-2998(05)80239-9","volume":"20","author":"E Kramer","year":"1990","unstructured":"Kramer E, Sanger J. Brain imaging in acquired immunodeficiency syndrome dementia complex. Semin Nucl Med 1990;20:353\u201363. doi: 10.1016\/S0001-2998(05)80239-9 .","journal-title":"Semin Nucl Med"},{"key":"1126_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2004.08.036","volume":"157","author":"KA Tucker","year":"2004","unstructured":"Tucker KA, Robertson KR, Lin W, et al. Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol 2004;157:153\u201316. doi: 10.1016\/j.jneuroim.2004.08.036 .","journal-title":"J Neuroimmunol"},{"key":"1126_CR10","first-page":"581","volume":"30","author":"A Brunetti","year":"1989","unstructured":"Brunetti A, Berg G, Chiro G, et al. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study. J Nucl Med 1989;30:581\u201390.","journal-title":"J Nucl Med"},{"key":"1126_CR11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/17520363.2.4.349","volume":"2","author":"S Bonham","year":"2008","unstructured":"Bonham S, Meya D, Bohjanen P, Boulware D. Biomarkers of HIV immune reconstitution inflammatory syndrome. Biomark Med 2008;2:349\u201361. doi: 10.2217\/17520363.2.4.349 .","journal-title":"Biomark Med"},{"key":"1126_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09540260701861930","volume":"20","author":"A Nath","year":"2008","unstructured":"Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J. Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 2008;20:25\u201331. doi: 10.1080\/09540260701861930 .","journal-title":"Int Rev Psychiatry"},{"key":"1126_CR13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1357-4310(99)01663-9","volume":"6","author":"M Cloyd","year":"2000","unstructured":"Cloyd M, Chen J, Wang I. How does HIV cause AIDS? The homing theory. Mol Med Today 2000;6:108\u201311. doi: 10.1016\/S1357-4310(99)01663-9 .","journal-title":"Mol Med Today"},{"key":"1126_CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.smim.2008.06.001","volume":"20","author":"M Lederman","year":"2008","unstructured":"Lederman M, Margolis L. The lymph node in HIV pathogenesis. Semin Immunol 2008;20:187\u201395. doi: 10.1016\/j.smim.2008.06.001 .","journal-title":"Semin Immunol"},{"key":"1126_CR15","first-page":"352","volume":"28","author":"S Bakheet","year":"2000","unstructured":"Bakheet S, Powe J. Benign causes of 18-FDG uptake on whole-body imaging. Semin Nucl Med 2000;28:352\u20138.","journal-title":"Semin Nucl Med"},{"key":"1126_CR16","first-page":"1854","volume":"36","author":"R Brown","year":"1995","unstructured":"Brown R, Leung J, Fisher S, Frey K, Ethier S, Wahl R. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: are inflammatory cells important? J Nucl Med 1995;36:1854\u201361.","journal-title":"J Nucl Med"},{"key":"1126_CR17","first-page":"1972","volume":"33","author":"R Kubota","year":"1992","unstructured":"Kubota R, Yamada S, Kubota K, Ishiwata KL, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-deoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972\u201380.","journal-title":"J Nucl Med"},{"key":"1126_CR18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mrm.1910290307","volume":"29","author":"M Bental","year":"1993","unstructured":"Bental M, Deutsch C. Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn Reson Med 1993;29:317\u201326. doi: 10.1002\/mrm.1910290307 .","journal-title":"Magn Reson Med"},{"key":"1126_CR19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-4827(91)90116-C","volume":"193","author":"S Marjanovic","year":"1991","unstructured":"Marjanovic S, Skog S, Heiden T, Tribukait B, Nelson B. Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res 1991;193:425\u201331. doi: 10.1016\/0014-4827(91)90116-C .","journal-title":"Exp Cell Res"},{"key":"1126_CR20","first-page":"701","volume":"21","author":"A Kwan","year":"2001","unstructured":"Kwan A, Seltzer M, Czernin J, Chou M, Kao C. Characterization of hilar lymph node by 18F-fluro-2-deoxyglucose positron emission tomography in healthy subjects. Anticancer Res 2001;21:701\u20136.","journal-title":"Anticancer Res"},{"key":"1126_CR21","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1073\/pnas.93.13.6425","volume":"93","author":"A Scharko","year":"1996","unstructured":"Scharko A, Perlman S, Hinds P, Hanson J, Uno H, Pauza D. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci U S A 1996;93:6425\u201330. doi: 10.1073\/pnas.93.13.6425 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1126_CR22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/viro.2000.0479","volume":"274","author":"M Wallace","year":"2000","unstructured":"Wallace M, Pyzalski R, Horejsh D, et al. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques. Virology 2000;274:255\u201361. doi: 10.1006\/viro.2000.0479 .","journal-title":"Virology"},{"key":"1126_CR23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(03)14366-8","volume":"20","author":"A Scharko","year":"2003","unstructured":"Scharko A, Perlman S, Pyzalski R, Graziano F, Sosman J, Pauza C. Whole-body positron emission tomography in patients with HIV-1 infection. Lancet 2003;20:959\u201361. doi: 10.1016\/S0140-6736(03)14366-8 .","journal-title":"Lancet"},{"key":"1126_CR24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(03)14363-2","volume":"20","author":"S Iyengar","year":"2003","unstructured":"Iyengar S, Chin B, Margolick J, Beulah P, Schwartz D. Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet 2003;20:945\u201350. doi: 10.1016\/S0140-6736(03)14363-2 .","journal-title":"Lancet"},{"key":"1126_CR25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.aids.0000210603.40267.29","volume":"20","author":"D Brust","year":"2006","unstructured":"Brust D, Polis M, Davey R, et al. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS 2006;20:495\u2013503.","journal-title":"AIDS"},{"key":"1126_CR26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00259-008-1023-7","volume":"36","author":"G Lucignani","year":"2009","unstructured":"Lucignani G, Orunesu E, Cesari M, et al. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging 2009;36:640\u20137. doi: 10.1007\/s00259-008-1023-7 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1126_CR27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/RLU.0b013e3181813047","volume":"33","author":"E Goshen","year":"2008","unstructured":"Goshen E, Davidson T, Avigdor A, Zwas T, Levy I. PET\/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads. Clin Nucl Med 2008;33:610\u20134. doi: 10.1097\/RLU.0b013e3181813047 .","journal-title":"Clin Nucl Med"},{"key":"1126_CR28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/apc.2008.0174","volume":"22","author":"PA Just","year":"2008","unstructured":"Just PA, Fieschi C, Baillet G, Galicier L, Oksenhendler E, Moretti JL. 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in AIDS-related Burkitt lymphoma. AIDS Patient Care STDS 2008;22:695\u2013700. doi: 10.1089\/apc.2008.0174 .","journal-title":"AIDS Patient Care STDS"},{"key":"1126_CR29","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093\u20139. doi: 10.1016\/S0140-6736(98)08468-2 .","journal-title":"Lancet"},{"key":"1126_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00002018-200023010-00004","volume":"23","author":"G Behrens","year":"2000","unstructured":"Behrens G, Stoll M, Schmidt R. Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? Drug Saf 2000;23:57\u201376. doi: 10.2165\/00002018-200023010-00004 .","journal-title":"Drug Saf"},{"key":"1126_CR31","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1172\/JCI200215626","volume":"110","author":"G Behrens","year":"2002","unstructured":"Behrens G, Boerner A, Weber K, et al. Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. J Clin Invest 2002;110:1319\u201327.","journal-title":"J Clin Invest"},{"key":"1126_CR32","first-page":"2430","volume":"18","author":"C Bleeker-Rovers","year":"2004","unstructured":"Bleeker-Rovers C, van der Ven A, Zomer B, et al. F-18-Fluorodexoyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients. AIDS 2004;18:2430\u20132.","journal-title":"AIDS"},{"key":"1126_CR33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAD.0b013e3282f2589b","volume":"22","author":"H Tsong Fang","year":"2008","unstructured":"Tsong Fang H, Colantonio A, Uittenbogaart C. The role of the thymus in HIV infection: a 10\u00a0year perspective. AIDS 2008;22:171\u20134. doi: 10.1097\/QAD.0b013e3282f2589b .","journal-title":"AIDS"},{"key":"1126_CR34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1468-1293.2004.00187.x","volume":"5","author":"G Hardy","year":"2004","unstructured":"Hardy G, Worrell S, Hayes P, et al. Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection. HIV Med 2004;5:67\u201373. doi: 10.1111\/j.1468-1293.2004.00187.x .","journal-title":"HIV Med"},{"key":"1126_CR35","first-page":"567","volume":"34","author":"JM Hoffman","year":"1993","unstructured":"Hoffman JM, Waskin HA, Schifter T, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993;34:567\u201375.","journal-title":"J Nucl Med"},{"key":"1126_CR36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00004728-199507000-00004","volume":"19","author":"K Villringer","year":"1995","unstructured":"Villringer K, Jager H, Dichgans M, et al. Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr 1995;19:532\u20136. doi: 10.1097\/00004728-199507000-00004 .","journal-title":"J Comput Assist Tomogr"},{"key":"1126_CR37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1258\/0956462961918239","volume":"7","author":"A Heald","year":"1996","unstructured":"Heald A, Hoffman JM, Bartlett J, Waskin H. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS 1996;7:337\u201346. doi: 10.1258\/0956462961918239 .","journal-title":"Int J STD AIDS"},{"key":"1126_CR38","first-page":"1575","volume":"38","author":"M O\u2019Doherty","year":"1997","unstructured":"O\u2019Doherty M, Barrington S, Campbell M, Lowe J, Bradbeer C. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997;38:1575\u201383.","journal-title":"J Nucl Med"},{"key":"1126_CR39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1570162043485095","volume":"2","author":"M Boska","year":"2004","unstructured":"Boska M, Mosley R, Nawab M, et al. Advances in neuroimaging for HIV-1 associated neurological dysfunction: clues to the diagnosis, pathogenesis and therapeutic monitoring. Curr HIV Res 2004;2:61\u201378. doi: 10.2174\/1570162043485095 .","journal-title":"Curr HIV Res"},{"key":"1126_CR40","first-page":"2169","volume":"36","author":"G Depas","year":"1995","unstructured":"Depas G, Chiron C, Tardieu M, et al. Functional brain imaging in HIV-1-infected children born to seropositive mothers. J Nucl Med 1995;36:2169\u201374.","journal-title":"J Nucl Med"},{"key":"1126_CR41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/jnp.7.2.180","volume":"7","author":"C Hinkin","year":"1995","unstructured":"Hinkin C, Van Gorp W, Mandelkern M, et al. Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci 1995;7:180\u20137.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1126_CR42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1176\/jnp.5.3.316","volume":"5","author":"T Newton","year":"1993","unstructured":"Newton T, Leuchter A, Walter D, et al. EEG coherence in men with AIDS: association with subcortical metabolic activity. J Neuropsychiatry Clin Neurosci 1993;5:316\u201321.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1126_CR43","first-page":"1133","volume":"37","author":"D Rottenberg","year":"1996","unstructured":"Rottenberg D, Sidtis J, Strother S, et al. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 1996;37:1133\u201341.","journal-title":"J Nucl Med."},{"key":"1126_CR44","first-page":"1177","volume":"37","author":"V Villemagne","year":"1996","unstructured":"Villemagne V, Phillips R, Liu X, et al. Peptide T and glucose metabolism in AIDS dementia complex. J Nucl Med 1996;37:1177\u201380.","journal-title":"J Nucl Med"},{"key":"1126_CR45","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.57.11.1601","volume":"57","author":"H Giesen von","year":"2000","unstructured":"von Giesen H, Antke C, Hefter H, Wenserski F, Seitz R, Arendt G. Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. Arch Neurol 2000;57:1601\u20137. doi: 10.1001\/archneur.57.11.1601 .","journal-title":"Arch Neurol"},{"key":"1126_CR46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.410220605","volume":"22","author":"D Rottenberg","year":"1987","unstructured":"Rottenberg D, Moeller J, Strother S, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987;22:700\u20136. doi: 10.1002\/ana.410220605 .","journal-title":"Ann Neurol"},{"key":"1126_CR47","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1176\/jnp.4.3.280","volume":"4","author":"W Gorp Van","year":"1992","unstructured":"Van Gorp W, Mandelkern M, Gee M, et al. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. J Neuropsychiatry Clin Neurosci 1992;4:280\u20137.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1126_CR48","first-page":"1725","volume":"32","author":"S Pascal","year":"1991","unstructured":"Pascal S, Resnick L, Barker W, et al. Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J Nucl Med 1991;32:1725\u20139.","journal-title":"J Nucl Med"},{"key":"1126_CR49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11481-006-9012-8","volume":"1","author":"R Rock","year":"2006","unstructured":"Rock R, Peterson P. Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimmune Pharmacol 2006;1:117\u201326. doi: 10.1007\/s11481-006-9012-8 .","journal-title":"J Neuroimmune Pharmacol"},{"key":"1126_CR50","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1212\/WNL.53.9.2199","volume":"53","author":"R Banati","year":"1999","unstructured":"Banati R, Goerres G, Myers R, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999;53:2199\u2013203.","journal-title":"Neurology"},{"key":"1126_CR51","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/brain\/124.10.2014","volume":"124","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Myers R, Gunn R, et al. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 2001;124:2014\u201327. doi: 10.1093\/brain\/124.10.2014 .","journal-title":"Brain"},{"key":"1126_CR52","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks D, Kennedy A, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461\u20137. doi: 10.1016\/S0140-6736(01)05625-2 .","journal-title":"Lancet"},{"key":"1126_CR53","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/13550280500187351","volume":"11","author":"D Hammoud","year":"2005","unstructured":"Hammoud D, Endres C, Chander A, et al. Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS. J Neurovirol 2005;11:346\u201355. doi: 10.1080\/13550280500187351 .","journal-title":"J Neurovirol"},{"key":"1126_CR54","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/13550280600873868","volume":"12","author":"C Wiley","year":"2006","unstructured":"Wiley C, Lopresti B, Becker J, et al. Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment. J Neurovirol 2006;12:262\u201371.","journal-title":"J Neurovirol"},{"key":"1126_CR55","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/brain\/awh269","volume":"127","author":"G Wang","year":"2004","unstructured":"Wang G, Chang L, Volkow N, et al. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 2004;127:2452\u20138. doi: 10.1093\/brain\/awh269 .","journal-title":"Brain"},{"key":"1126_CR56","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuroimage.2008.05.011","volume":"42","author":"L Chang","year":"2008","unstructured":"Chang L, Wang G, Volkow N, et al. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage 2008;42:869\u201378. doi: 10.1016\/j.neuroimage.2008.05.011 .","journal-title":"Neuroimage"},{"key":"1126_CR57","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/CCO.0b013e32830a5080","volume":"20","author":"F Bonnet","year":"2008","unstructured":"Bonnet F, Ch\u00eane G. Evolving epidemiology of malignancies in HIV. Curr Opin Oncol 2008;20:534\u201340.","journal-title":"Curr Opin Oncol"},{"key":"1126_CR58","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","volume":"27","author":"T Powles","year":"2009","unstructured":"Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009;27:884\u201390.","journal-title":"J Clin Oncol"},{"key":"1126_CR59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11904-008-0022-4","volume":"5","author":"R Bedimo","year":"2008","unstructured":"Bedimo R. Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. Curr HIV\/AIDS Rep 2008;5:140\u20139. doi: 10.1007\/s11904-008-0022-4 .","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1126_CR60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","volume":"2","author":"N Crum-Cianflone","year":"2009","unstructured":"Crum-Cianflone N, Hullsiek K, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009;2:41\u201350. doi: 10.1097\/QAD.0b013e328317cc2d .","journal-title":"AIDS"},{"issue":"2 Suppl 2","key":"1126_CR61","first-page":"S2-189","volume":"18","author":"A Mayor","year":"2008","unstructured":"Mayor A, Gomez M, Rios-Olivares E, Hunter-Mellado R. AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy. Ethn Dis 2008;18(2 Suppl 2):S2-189\u2013S2-194.","journal-title":"Ethn Dis"},{"key":"1126_CR62","first-page":"151","volume":"48","author":"A Chitale","year":"2005","unstructured":"Chitale A. Cancer and AIDS. Indian J Pathol Microbiol 2005;48:151\u201360.","journal-title":"Indian J Pathol Microbiol"},{"key":"1126_CR63","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1086\/533419","volume":"197","author":"R Price","year":"2008","unstructured":"Price R, Spudich S. Antiretroviral therapy and central nervous system HIV type-1 infection. J Infect Dis 2008;197:S294\u2013S306. doi: 10.1086\/533419 .","journal-title":"J Infect Dis"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1126-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1126-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:01:46Z","timestamp":1558699306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1126-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1126-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,7]]}}}